Latest News Archives - Page 2 of 2

Pierre Fabre Collaboration

Posted on: January 20, 2016

Pharma and cosmetics multinational Pierre Fabre selects BioAscent as central hub for storage and logistics of extensive plant natural products collection Today, BioAscent announces a new collaboration with pharmaceutical and cosmetics multinational, Pierre Fabre, as part of an open innovation initiative promoting … Continued

A New Library for Phenotypic Screening: the Annotation Challenge

Posted on: November 16, 2015

BioAscent have released a new compound library for phenotypic screening – providing capabilities beyond what is currently available. The Phenotypic Toolbox combines a set of chemically diverse compounds together with reference compounds with known Mechanism of Action. Uniquely, the library is supplied … Continued

The Revival of a Compound Management Facility

Posted on: May 4, 2015

Aaron Sutherland and Steven Russell will explain at Titian Users Group Meeting on 20-21 May in London how recommissioning our facility with Titian’s Mosaic Software was essential to the success of our operations. Read more on the white paper, The Revival of a … Continued

Novel Cell Penetration-Designed Compound Set

Posted on: November 6, 2014

Drug discovery open innovation – beyond the Rule of 5. Do you have a novel cell-based assay? Looking to find novel compounds custom designed to penetrate cells? Our partner is offering access to a compound set designed with specific biological … Continued

BioAscent on front cover of EBR Journal

Posted on: October 8, 2014

We’re excited that our lab automation features on the front cover of this month’s European Biopharmaceutical Review.

Drug Discovery Open Innovation: Maximising Diversity of Shared Compound Collections

Posted on: October 8, 2014

Considering embarking on an innovation-driven collaboration involving your compound collection? — How can you be sure you will access novel chemistry from your partner? Open Innovation Open innovation in drug discovery through sharing compound collections, enables access to new … Continued

Accelerating Drug Discovery Innovation

Posted on: October 7, 2014

Compound collections are a valuable corporate asset capable of being utilised to promote and drive innovation in early-stage drug discovery. In our article in the EBR journal, we review current models aiming to maximise the return on investment of compound … Continued

BioAscent sponsors 10th Intelligent Compound Libraries 2014

Posted on: July 21, 2014

We are attending and proudly sponsoring the Pharma IQ (IQPC) 10th Intelligent Compound Libraries 2014 International Conference on 27-29 October 2014 in Berlin, Germany.

Compound Collection Sharing: A New Model of Drug Discovery Innovation

Posted on: April 6, 2014

The sharing of corporate compound collections was until recently very challenging. However last year’s successful creation of the European Lead Factory (ELF), and now an announcement from Astellas Pharma and Daiichi Sankyo, have demonstrated a workable model. Combining corporate compound … Continued

BioAscent is Compound Management “Centre of Excellence” for IMI European Lead Factory

Posted on: January 1, 2013

BioAscent have been selected as the Compound Logistics “Centre of Excellence” for the IMI European Lead Factory (ELF), and manage the 500,000 compound, Joint European Compound Collection. 300,000 novel small molecules provided by 7 EU pharma partners 200,000 new scaffolds from SMEs for … Continued